国家药监局:化妆品禁用原料目录更新!

2021-05-31 rayms 国家药监局

为进一步加强化妆品原料管理,保证化妆品质量安全,依据《化妆品监督管理条例》相关规定,国家药品监督管理局组织对《化妆品安全技术规范(2015年版)》更新。

为进一步加强化妆品原料管理,保证化妆品质量安全,依据《化妆品监督管理条例》相关规定,国家药品监督管理局组织对《化妆品安全技术规范(2015年版)》(以下简称《规范》)第二章中的《化妆品禁用组分(表1)》《化妆品禁用植(动)物组分(表2)》进行了修订,形成了《化妆品禁用原料目录》《化妆品禁用植(动)物原料目录》,经化妆品标准专家委员会全体会议审议通过,现予以发布,分别替代原有禁用组分表,并纳入《规范》相应章节。

 

本公告自发布之日起施行。自本公告发布之日起,化妆品注册人、备案人不得生产、进口产品配方中使用了《化妆品禁用原料目录》《化妆品禁用植(动)物原料目录》规定的禁用原料的化妆品。

附件:

1.《化妆品禁用原料目录》

2.《化妆品禁用植(动)物原料目录》

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1301744, encodeId=40fe1301e44c0, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346893, encodeId=3c2d1346893c4, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429278, encodeId=d6c114292e8c7, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
    2021-06-02 xuyu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1301744, encodeId=40fe1301e44c0, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346893, encodeId=3c2d1346893c4, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429278, encodeId=d6c114292e8c7, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1301744, encodeId=40fe1301e44c0, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346893, encodeId=3c2d1346893c4, content=<a href='/topic/show?id=75e0334e76e' target=_blank style='color:#2F92EE;'>#化妆品#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33477, encryptionId=75e0334e76e, topicName=化妆品)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429278, encodeId=d6c114292e8c7, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Wed Jun 02 01:28:40 CST 2021, time=2021-06-02, status=1, ipAttribution=)]